The Q4 Influenza A H5N1 Infection pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Influenza A H5N1 Infection, provides an update on the mechanism of action and targets, licensing and collaboration opportunities, company profiles including their business information, and market developments.
Influenza A H5N1 Infection Disease Types, Symptoms, Causes, and Available Treatment Options The comprehensive report on the indication presents Influenza A H5N1 Infection disease overview, Influenza A H5N1 Infection types, Influenza A H5N1 Infection symptoms, causes, and FDA/EMA approved treatment options.
Influenza A H5N1 Infection Pipeline Trends and Insights The year 2020 witnessed progress in innovations and the number of pipeline agents researched for Influenza A H5N1 Infection indication. The report presents near-term and long-term pipeline development trends and potential insights.
Influenza A H5N1 Infection Company Trends and Insights The report analyzes the development progress, current status, investments, partnerships, and other developments of 37 companies. Business profiles and contact details of the companies actively perusing Influenza A H5N1 Infection pipeline are assessed.
Influenza A H5N1 Infection R&D Pipeline Development Phase Trends and Insights From the discovery stage of development to phase 3 development, all the potential pipeline drug candidates are analyzed in the report. Influenza A H5N1 Infection discovery stage, research stage, Phase 1, phase 2, Phase 3, IND enabling studies are provided in the research.
Small Influenza A H5N1 Infection companies look for licensing and collaboration partners
High R&D costs and long duration pose challenges for small companies operating in the industry. Further, the presence of large companies and stringent regulations act as barriers for Influenza A H5N1 Infection pipeline development companies. Accordingly, a significant portion of small companies presents potential licensing and collaboration opportunities.
Influenza A H5N1 Infection Pipeline Market News and Developments during 2020
The Influenza A H5N1 Infection industry news, pipeline research, market developments including advancement in phases, pre-clinical study results, clinical trial launches, acquisitions and mergers, regulatory approvals, and others are included in the report.
Influenza A H5N1 Infection Mechanism of Action and Targets Leading Mechanism of Action and targets being researched by all the companies and their progress is included. New mechanisms of actions introduced during the year, route of administration, orphan drug designation, and others are provided in the study.
New molecular entity details Drug candidates identified as new molecular entities by FDA, EMA, and other regulators are included in the research.
Sources and Research Methodology Data is updated daily across diseases in the infectious pipeline service. We review our quarterly pipeline reports for the latest 5 years to present longitudinal insights.
Scope and Coverage • Influenza A H5N1 Infection pipeline development activities across the early phase, mid-stage, and late phase pipelines including therapeutic candidates
• Drug profiles comprising of drug overview, mechanism of action, co-developers, originators, route of administration, molecule type, orphan drug status, new molecular entity, area, and other details.
• Company-company partnerships, company-institute partnerships, and investment details of companies are included
• 37 companies are included including Abivax SA, Abzyme Therapeutics LLC, AIM ImmunoTech Inc, Akshaya Bio Inc, Altimmune Inc, Aphios Corp, AusBio Ltd, BiondVax Pharmaceuticals Ltd, CEL-SCI Corp, Chicago Biosolutions Inc, CHO Pharma Inc, Cocrystal Pharma Inc, Curevac AG, Declion Pharmaceuticals Inc, FluGen Inc, Gamma Vaccines Pty Ltd, Global BioLife Inc Ltd, Greffex Inc, i2 Pharmaceuticals Inc, Inovio Pharmaceuticals Inc, Johnson & Johnson, Medicago Inc, Medigen Inc, NanoViricides Inc, New Amsterdam Sciences Inc, NuGenerex Immuno-Oncology Inc, PeptiDream Inc, Pneumagen Ltd, Seqirus Ltd, Shionogi & Co Ltd, TechnoVax Inc, Tria Bioscience Corp, Vacthera BioTech GmbH, Vaxart Inc, Vaxine Pty Ltd, Virion Biotherapeutics, Virvio Inc,
• Disease overview, Pipeline trends, market analysis, and other developments
• Potential licensing/new business opportunities in Influenza A H5N1 Infection pipeline market
Highlights • Global coverage of companies and pipeline agents
• 2020 Trends, market analysis, and developments
• Potential growth opportunities
• Comprehensive details of drug candidates
Reasons to Buy • Drive pipeline research and commercial assessment
• Assess most promising drug candidates and stay ahead of the competition
• Strengthen your pipeline through identifying business expansion and acquisition opportunities
• Develop new candidates based on most focused targets and mechanism of actions
Our reports have been used by over 10K customers, including:
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The Global Magnetic Beads Market size is expected to reach $2 billion by 2026, rising at a market growth of 12.7% CAGR during the forecast period. Magnetic beads refer to a tool, which is made up of small particles of iron oxides like magnetite that provide superparamagnetic properties to these beads. They do not attract one another when they...
573 pages •
By Global Industry Analysts
• Apr 2021
- Looking Beyond Today’s Challenges to Tomorrow’s Healthcare Needs. Genetic Testing to Reach $18.9 Billion as the Burden of Non-Communicable Diseases Grows Bigger
- The global market for Genetic Testing is forecast to reach US$18.9 billion by the year 2027, trailing a post COVID-19 CAGR of 8.6% over the...
278 pages •
By Global Industry Analysts
• Apr 2021
- Global Anatomic Pathology Market to Reach $26.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Anatomic Pathology estimated at US$18.7 Billion in the year 2020, is projected to reach a revised size of US$26.3 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027....
185 pages •
By Global Industry Analysts
• Apr 2021
- Global Pathology Instruments Market to Reach $4.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pathology Instruments estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027....
Melanoma - Epidemiology Forecast to 2029
Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of the skin (World Health Organization, 2017).Melanocytes are embryological derivatives of neural crest tissue, and...
120 pages •
By Infiniti Research Limited
• Mar 2021
Global Pathology Instruments Market 2021-2025 The analyst has been monitoring the pathology instruments market and it is poised to grow by $ 1.23 bn during 2021-2025 progressing at a CAGR of 6% during the forecast period. Our report on pathology instruments market provides a holistic analysis, market size and forecast,...
200 pages •
By The Business Research Company
• Mar 2021
Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold. The global ultra-low temperature freezers market is expected to decline from $633.94 million...
Anatomic Pathology Market Report Overview Anatomic Pathology market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anatomic Pathology market types and applications. It is a focused study on Anatomic Pathology market space including global...
Pathology Devices Market Report Overview Pathology Devices market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pathology Devices market types and applications. It is a focused study on Pathology Devices market space including global and...
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.